Biomarkers of acute kidney injury: a concise review of current literature
By:
References
- Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012 Aug 24; 380(9843):756-66. DOI: 10.1016/S0140-6736(11)61454-2
- Simsek A, Tugcu V, Tasci AI. New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol. 2012 Nov 1;2013:394582. DOI: 10.5402/2013/394582
- Ostermann M, Karsten E, Lumlertgul N. Biomarker-Based Management of AKI: Fact or Fantasy? 2022;146(3):295-01. DOI: 10.1159/000518365
- Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury-pathophysiological basis and clinical performance. Acta Physiol (Oxf). 2017 Mar;219(3):554-72. DOI: 10.1111/apha.12764
- Albert C, Haase M, Albert A, Zapf A, Braun-Dullaeus RC, Haase-Fielitz A. Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?. Ann Lab Med. 2021 Jan;41(1):1-15. DOI: 10.3343/alm.2021.41.1.1
- Zhang WR, Parikh CR. Biomarkers of Acute and Chronic Kidney Disease. Annu Rev Physiol. 2019 Feb 10;81:309-33. DOI: 10.1146/annurev-physiol-020518-114605
- Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis. 2008 Jul;15(3):222-34. DOI: 10.1053/j.ackd.2008.04.003
- Teo SH, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol. 2017 Sep;31(3):331-44. DOI: 10.1016/j.bpa.2017.10.003
- Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci. 2021 Aug;58(5):354-68. DOI: 10.1080/10408363.2021.1879000
- Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013 Oct;76(4):516-23. DOI: 10.1111/bcp.12104
- George Bakris. Proteinuria A Link to Understanding Changes in Vascular Compliance? Hypertension. 2005 Sep1; 46 (3):473-74. DOI: 10.1161/01.HYP.0000178188.29446.48
- Pugh D, Gallacher PJ, Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs. 2019 Mar;79(4):365-79. DOI: 10.1007/s40265-019-1064-1
- Jiang W, Chen Z, Xu J, Luo Z, Teng J, Ding X, et al. Proteinuria is a risk factor for acute kidney injury after cardiac surgery in patients with stages 3-4 chronic kidney disease: a case control study. BMC Cardiovasc Disord. 2023 Feb 10;23(1):77. DOI: 10.1186/s12872-023-03102-4
- Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463-93. DOI: 10.1146/annurev.pharmtox.48.113006.094615
- Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-Associated Acute Kidney Injury. Crit Care Clin. 2021 Apr;37(2):279-01. DOI: 10.1016/j.ccc.2020.11.010
- Brodie AC, Johnston TJ, Lloyd P, Hemsworth L, Barabas M, Keoghane SR. Reducing the rate of negative ureteroscopy: predictive factors and the role of preoperative imaging. Ann R Coll Surg Engl. 2022 Sep;104(8):588-93. DOI: 10.1308/rcsann.2021.0260
- Zou C, Wang C, Lu L. Advances in the study of subclinical AKI biomarkers. Front Physiol. 2022 Aug 24;13:960059. DOI: 10.3389/fphys.2022.960059
- Rehberg PB. Studies on Kidney Function: The Rate of Filtration and Reabsorption in the Human Kidney. Biochem J. 1926;20(3):447-60. DOI: 10.1042/bj0200447
- Grubb AO. Cystatin C--properties and use as diagnostic marker. Adv Clin Chem. 2000;35:63-99. DOI: 10.1016/S0065-2423(01)35015-1
- Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985 Nov;28(5):830-38. DOI: 10.1038/ki.1985.205
- Murty MS, Sharma UK, Pandey VB, Kankare SB. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol. 2013 May;23(3):180-83. DOI: 10.4103/0971-4065.111840
- Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med. 1999 Apr;37(4):389-95. DOI: 10.1515/CCLM.1999.064
- Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004 Sep;66(3):1115-22. DOI: 10.1111/j.1523-1755.2004.00861.x
- Nejat M, Pickering JW, Walker RJ, Endre ZH. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant. 2010 Oct;25(10):3283-89. DOI: 10.1093/ndt/gfq176
- Nakhjavan-Shahraki B, Yousefifard M, Ataei N, Baikpour M, Ataei F, Bazargani B, et al. Accuracy of cystatin C in prediction of acute kidney injury in children; serum or urine levels: which one works better? A systematic review and meta-analysis. BMC Nephrol. 2017 Apr 3;18(1):120. DOI: 10.1186/s12882-017-0539-0
- Bell M, Granath F, Mårtensson J, Löfberg E, Ekbom A, Martling CR (Karolinska Intensive care Nephrology Group). Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant. 2009 Oct;24(10):3096-102. DOI: 10.1093/ndt/gfp196
- Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008 Oct;74(8):1059-069. DOI: 10.1038/ki.2008.341
- Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, et al. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010 May 18;121(19):2117-122. DOI: 10.1161/CIRCULATIONAHA.109.919639
- Soto K, Coelho S, Rodrigues B, Martins H, Frade F, Lopes S, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol. 2010 Oct;5(10):1745-54. DOI: 10.2215/CJN.00690110
- Haines RW, Fowler AJ, Liang K, Pearse RM, Larsson AO, Puthucheary Z, et al. Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness. Clin J Am Soc Nephrol. 2023 Aug 1;18(8):997-005. DOI: 10.2215/CJN.0000000000000203
- Wyler von Ballmoos M, Likosky DS, Rezaee M, Lobdell K, Alam S, Parker D, et al. Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery. BMC Nephrol. 2018 Oct 20;19(1):280. DOI: 10.1186/s12882-018-1093-0
- Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med. 2011 Nov;39(11):2464-69. DOI: 10.1097/CCM.0b013e318225761a
- Burrello J, Monticone S, Burrello A, Bolis S, Cristalli CP, Comai G, et al. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant. Nephrol Dial Transplant. 2023 Feb 28;38(3):764-77. DOI: 10.1093/ndt/gfac259
- Guo Y, Li L, Hu S. Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis. BMC Nephrol. 2023 Jun 8;24(1):163. DOI: 10.1186/s12882-023-03226-x
- Kikuchi Y, Kobayashi S, Hemmi N, Ikee R, Hyodo N, Saigusa T, et al. Galectin-3-positive cell infiltration in human diabetic nephropathy. Nephrol Dial Transplant. 2004 Mar;19(3):602-07. DOI: 10.1093/ndt/gfg603
- Hara A, Niwa M, Noguchi K, Kanayama T, Niwa A, Matsuo M, et al. Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases. Biomolecules. 2020 Mar 3;10(3):389. DOI: 10.3390/biom10030389
- Al-Salam S, Jagadeesh GS, Sudhadevi M, Yasin J. Galectin-3 and Autophagy in Renal Acute Tubular Necrosis. Int J Mol Sci. 2024 Mar 22;25(7):3604. DOI: 10.3390/ijms25073604
- Horiuchi Y, Wettersten N, Van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure. J Card Fail. 2023 Mar;29(3):269-77. DOI: 10.1016/j.cardfail.2022.09.017
- Sun H, Peng J, Cai S, Nie Q, Li T, Kellum JA, et al. A translational study of Galectin-3 as an early biomarker and potential therapeutic target for ischemic-reperfusion induced acute kidney injury. J Crit Care. 2021 Oct;65:192-99. DOI: 10.1016/j.jcrc.2021.06.013
- Younes-Ibrahim M, Younes-Ibrahim M. Biomarkers and kidney diseases: a brief narrative review. J Lab Prec Med. 2022 Jul 30; 7:20. DOI: 10.21037/jlpm-22-1
- Yu B, Jin L, Yao X, Zhang Y, Zhang G, Wang F, et al. TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy. Theranostics. 2023 Jul 31;13(13):4356-75. DOI: 10.7150/thno.84655
- Volarevic V, Markovic BS, Jankovic MG, Djokovic B, Jovicic N, Harrell CR, et al. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Theranostics. 2019 Aug 14;9(20):5976-001. DOI: 10.7150/thno.33959
- Zhao Y, Feng X, Li B, Sha J, Wang C, Yang T, et al. Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway. Front Pharmacol. 2020 Feb25; 25(11):128. DOI: 10.3389/fphar.2020.00128
- Li HY, Yang S, Li JC, Feng JX. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity. Biosci Rep. 2018 Dec 18;38(6):BSR20181803. DOI: 10.1042/BSR20181803
- Tanase DM, Gosav EM, Radu S, Costea CF, Ciocoiu M, Carauleanu A, et al. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity. Int J Mol Sci. 2019 Oct 2022;20(20):5238. DOI: 10.3390/ijms20205238
- Vogel MJ, Mustroph J, Staudner ST, Leininger SB, Hubauer U, Wallner S, et al. Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19. J Nephrol. 2021 Aug;34(4):1007-018. DOI: 10.1007/s40620-021-01079-x
- Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014 Oct;25(10):2177-86. DOI: 10.1681/ASN.2013070758
- Nica S, Nica RI, Toma M, Cimponeriu D, Cirstoiu FC, Cimpoesu DC.The interactions between risk factors for ischemic stroke. RJMM.2021 Jan; 124 (1):119-23. DOI: 10.55453/rjmm.2021.124.1.18
- Tonkonogi A, Carlsson AC, Helmersson-Karlqvist J, Larsson A, Ärnlöv J. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. Ups J Med Sci. 2016 Aug; 21(3):174-78. DOI: 10.1080/03009734.2016.1192704
- Brilland B, Boud’hors C, Wacrenier S, Blanchard S, Cayon J, Blanchet O, et al. Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis. Clin Kidney J. 2023 Apr 3;16(9):1521-33. DOI: 10.1093/ckj/sfad071
- Tu Y, Wang H, Sun R, Ni Y, Ma L, Xv F, et al. Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014 Nov;36(10):1559-63. DOI: 10.3109/0886022X.2014.949764
- Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009 Nov;24(11):3265-68. DOI: 10.1093/ndt/gfp010
- Abbas M, Alossaimi MA, Altamimi ASA, Alajaji M, Watson DG, Shah SI, et al. Determination of α1-acid glycoprotein (AGP) concentration by HPLC in patients following local infiltration analgesia for primary total hip arthroplasty and its relation to ropivacaine (total and unbound). Front Pharmacol. 2023 Jun 26;14:1145962. DOI: 10.3389/fphar.2023.1145962
- Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol. 2015 JAN 7;10(1):147-55. DOI: 10.2215/CJN.12191213
- Parikh CR, Liu C, Mor MK, Palevsky PM, Kaufman JS, Thiessen Philbrook H, et al. Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial. Am J Kidney Dis. 2020 Feb;75(2):187-94. DOI: 10.1053/j.ajkd.2019.06.011
- Zhen XW, Song NP, Ma LH, Ma LN, Guo L, Yang XD. Calprotectin and Neutrophil Gelatinase-Associated Lipocalin As Biomarkers of Acute Kidney Injury in Acute Coronary Syndrome. Am J Med Sci. 2021 Jun; 361(6):736-43. DOI: 10.1016/j.amjms.2020.10.028
- Yoon SY, Kim JS, Jeong KH, Kim SK. Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. Medicina (Kaunas). 2022 Feb 23;58(3):340. DOI: 10.3390/medicina58030340
- Canney M, Clark EG, Hiremath S. Biomarkers in acute kidney injury: On the cusp of a new era?. J Clin Invest. 2023 Jul 3;133(13):e171431. DOI: 10.1172/JCI171431
- Tan D, Zhao L, Peng W, Wu FH, Zhang GB, Yang B, et al. Value of urine IL-8, NGAL and KIM-1 for the early diagnosis of acute kidney injury in patients with ureteroscopic lithotripsy related urosepsis. Chin J Traumatol. 2022 Jan;25(1):27-31. DOI: 10.1016/j. cjtee.2021.10.001
- Liu Z, Yang D, Gao J, Xiang X, Hu X, Li S, et al. Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis. Theranostics. 2020 Oct 25;10(26):11963-75. DOI: 10.7150/thno.50093
- Rossiter A, La A, Koyner JL, Forni LG. New biomarkers in acute kidney injury. Crit Rev Clin Lab Sci. 2024 Jan; 61(1):23-44. DOI: 10.1080/10408363.2023.2242481
- Vakili M, Fahimi D, Esfahani ST, Sharifzadeh M, Moghtaderi M. Comparative Analysis between Urinary Calprotectin and Serum Creatinine for Early Detection of Intrinsic Acute Kidney Injury. Indian J Nephrol. 2021 Jul-Aug;31(4):353-57. DOI: 10.4103/ijn. IJN_83_20
- Chen JJ, Fan PC, Kou G, Chang SW, Chen YT, Lee CC, et al. Meta-Analysis: Urinary Calprotectin for Discrimination of Intrinsic and Prerenal Acute Kidney Injury. J Clin Med. 2019 Jan 10;8(1):74. DOI: 10.3390/jcm8010074
- https://emedicine.medscape.com/article/1925619-overview#a3 Accessed June 2024
Language: English
Page range: 305 - 313
Submitted on: Jun 28, 2024
Accepted on: Sep 26, 2024
Published on: Nov 6, 2024
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2024 Ileana Adela Văcăroiu, Andra Elena Balcangiu-Stroescu, Larisa Florina Șerban-Feier, Elena Cuiban, Ioana Sorina Simion, Iulia Ioana Stănescu-Spînu, Daniela Miricescu, Maria Greabu, Liviu Vasile Chiperi, Daniela Gabriela Bălan, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.